Skip to contentClarengateINTELLIGENCE
Companies/09061413

Aptamer Group PLC

Research and experimental development on biotechnology · York

ActiveUnited KingdomIncorporated 2014Public Limited Company
Register Ask analyst

Documents & history

Available account evidence and business events. This is not a complete filing history or document library.

Accounts to 2020-03-31

IXBRL · 190 source facts · 25 selected values

Not assessed
legacy record
Reporting period
2019-04-01 to 2020-03-31
Extraction status
Legacy / not assessed
Numeric facts
114
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2019-01-01.xsd
Currency
GBP
Source identifier
Prod224_0086_09061413_20200331
Source archive
Accounts_Monthly_Data-January2021.zip

Accounts to 2017-03-31

IXBRL · 188 source facts · 26 selected values

Not assessed
legacy record
Reporting period
2016-04-01 to 2017-03-31
Extraction status
Legacy / not assessed
Numeric facts
118
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
FRS-102-2014-09-01.xsd
Currency
GBP
Source identifier
Prod224_0048_09061413_20170331
Source archive
Accounts_Monthly_Data-October2017.zip

Accounts to 2016-03-31

IXBRL · 94 source facts · 18 selected values

Not assessed
legacy record
Reporting period
2015-06-01 to 2016-03-31
Extraction status
Legacy / not assessed
Numeric facts
46
Documents processed
Not recorded
XBRL standards validation
Not assessed
Filing-profile validation
Not assessed
Parser
Legacy parser
Taxonomy
uk-gaap-full-2009-09-01.xsd
Currency
GBP
Source identifier
Prod224_0033_09061413_20160331
Source archive
Accounts_Monthly_Data-August2016.zip

Registered details

09061413
Status
Active
Type
Public Limited Company
Incorporated
2014-05-29
Jurisdiction
—
Registered office
WINDMILL HOUSE, INNOVATION WAY, YORK, YO10 5BR, ENGLAND

Classification

1 SIC codes
72110

Capital & company events

Reconstructed equity rounds and matched research funding.

Equity fundraising

5 SH01-derived rounds
2026-03-24
£4,548,993 raised
£17,562,370 estimated post-money
2025-07-09
£2,081,999 raised
£7,957,517 estimated post-money
2024-12-06
£135,000 raised
£3,975,687 estimated post-money
2024-07-29
£2,906,000 raised
£3,840,687 estimated post-money
2023-08-17
£3,907,588 raised
£4,707,472 estimated post-money

Research and innovation

1 matched grants
MiracleLead
Innovate UK · Collaborative R&D · 2023-05-01 – 2025-04-30
£178,070
awarded